Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

FIRST: Pfizer-BioNTech gets USFDA emergency use nod for COVID vaccine in kids aged 5 through 11 years old

Ruchika Sharma30 Oct 2021 1:31 PM IST

New York: Pfizer Inc. and BioNTech SE have recently announced that the U.S. Food and Drug Administration (USFDA) has authorized for emergency use...

Russian COVID vaccine: Dr Reddys likely to submit Sputnik light trial data to DCGI in November

Ruchika Sharma30 Oct 2021 11:00 AM IST

New Delhi: Dr. Reddy's Laboratories Ltd is expected to submit Phase 3 trials data of single-dose Russian COVID-19 vaccine Sputnik Light to the Indian...

We trust Indian industry, Bharat Biotech has been submitting data regularly, very quickly: WHO official on Covaxin EUL

Ruchika Sharma29 Oct 2021 3:46 PM IST

United Nations/Geneva: India's Bharat Biotech has been submitting data on the EUL of Covaxin "regularly and very quickly" to a technical committee...

Bharat Biotech Covaxin finds place in Oman list of approved COVID vaccines

Ruchika Sharma29 Oct 2021 3:46 PM IST

New Delhi: Bharat Biotech's Covaxin has been included to the approved list of COVID-19 vaccines for travel to Oman without quarantine.In a tweet,...

Pfizer, BioNTech to provide additional 50 Million Pediatric doses of COVID-19 Vaccine to US

Ruchika Sharma29 Oct 2021 3:33 PM IST

New York: Pfizer Inc. and BioNTech SE have announced that the U.S. government has purchased 50 million more doses of the companies' COVID-19 vaccine....

Novavax files for COVID vaccine authorization in UK

Ruchika Sharma29 Oct 2021 2:26 PM IST

Gaithersburg: Novavax, Inc. has recently announced the completion of its rolling regulatory submission to the U.K. Medicines and Healthcare...

Tens of millions of JnJ COVID shots sit at Baltimore factory: Report

Ruchika Sharma29 Oct 2021 10:00 AM IST

New Delhi: An estimated 30 million to 50 million doses of Johnson & Johnson's COVID-19 vaccine made early this year sits idle in Emergent...

Merck to share molnupiravir formula with poor countries, enters agreement with MPP

Ruchika Sharma28 Oct 2021 5:23 PM IST

Geneva: To ensure the affordable global access for molnupiravir, pharma giant Merck (MSD) has entered into a voluntary licencing...

Sun Pharma arm launches PrILUMYA to treat plaque psoriasis in Canada

Ruchika Sharma28 Oct 2021 4:59 PM IST

Mumbai: Sun Pharma Canada Inc., a wholly owned subsidiary of Sun Pharmaceuticals Industries Limited today announced that PrILUMYA (tildrakizumab...

Make India manufacturing hub: Mansukh Mandaviya urges Pharma industry

Ruchika Sharma28 Oct 2021 2:17 PM IST

New Delhi: Union Chemicals and Fertilisers Minister Mansukh Mandaviya on Wednesday urged the pharma industry to make India manufacturing hub as...

Bharat Biotech US partner Ocugen files for clinical trials of Covaxin

Ruchika Sharma28 Oct 2021 2:16 PM IST

Malvern: Ocugen, Inc., has announced that the company has submitted an Investigational New Drug application (IND) with the U.S. Food and Drug...

Moderna COVID vaccine could start being used in children, teens within weeks: CEO

Ruchika Sharma28 Oct 2021 10:00 AM IST

New Delhi: Moderna Inc's COVID-19 vaccine could start to be used in children and teens in the United States within weeks, its chief executive said in...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok